Acceptability of HPV Vaccines: A Qualitative Systematic Review and Meta-Summary

Author:

Urrutia María-Teresa1ORCID,Araya Alejandra-Ximena1,Gajardo Macarena2,Chepo Macarena1ORCID,Torres Romina3,Schilling Andrea4ORCID

Affiliation:

1. School of Nursing, Universidad Andrés Bello, Santiago 8370134, Chile

2. School of Medicine, Universidad de Chile, Santiago 9170022, Chile

3. Sistema de Bibliotecas UC, Pontificia Universidad Católica de Chile, Santiago 8331150, Chile

4. Clinical Research Center, Institute of Science and Innovation in Medicine, Facultad de Medicina, Clinica Alemana Universidad del Desarrollo, Santiago 7610315, Chile

Abstract

In 2006, the human papillomavirus (HPV) vaccine was approved for use as an effective intervention for reducing the risk of developing cervical cancer; however, its successful implementation is dependent on acceptability. This study aims to provide a comprehensive understanding of the reasons that favor or do not favor the acceptability of HPV vaccines. Methods: We conducted a systematic review and meta-summary of qualitative research on 16 databases. A total of 32 articles that considered the perspectives of vaccine users, their parents, and the professionals who care for them were reviewed. Synthesis was conducted as described by Sandelowski and Barroso. Results: We used inductive and deductive methods to obtain a total of 22 dimensions, out of which three issues stood out that should be considered to improve acceptability and are formed by three groups of study, namely, information about the vaccine, fears and side effects, and sexuality associated with the vaccine. Conclusions: Acceptability, as well as adherence to HPV vaccination, is a complex concept. This review highlights the perspectives of the three sets of actors involved in the process (i.e., users, parents, and professionals) and views these factors in relation to acceptability as a guide for new interventions.

Funder

Fondo Nacional de Investigación en Salud-Chile/National Fund for Health Research

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference68 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. Bruni, L., Albero, G., Serrano, B., Mena, M., Collado, J.J., Gómez, D., Muñoz, J., Bosch, F.X., and de Sanjosé, S. (2023, July 26). ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023. Available online: https://hpvcentre.net/statistics/reports/ZAF.pdf?t=1668367618799.

3. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: Updated systematic review and meta-analysis;Drolet;Lancet,2019

4. World Health Organization (2022, June 14). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva 2020. Licence: CC BY-NC-SA 3.0 IGO. Available online: https://www.who.int/publications/i/item/9789240014107.

5. An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy;Yousefi;Front. Immunol.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3